A MISSENSE MUTATION (1278T) IN THE CYSTATHIONINE BETA-SYNTHASE GENE PREVALENT IN PYRIDOXINE-RESPONSIVE HOMOCYSTINURIA, AND ASSOCIATED WITH MILD CLINICAL PHENOTYPE
Ve. Shih et al., A MISSENSE MUTATION (1278T) IN THE CYSTATHIONINE BETA-SYNTHASE GENE PREVALENT IN PYRIDOXINE-RESPONSIVE HOMOCYSTINURIA, AND ASSOCIATED WITH MILD CLINICAL PHENOTYPE, American journal of human genetics, 57(1), 1995, pp. 34-39
Cystathionine beta-synthase (CBS) deficiency is an autosomal recessive
disorder characterized by homocystinuria and multisystem clinical dis
ease. Patients responsive to pyridoxine usually have a milder clinical
phenotype than do nonresponsive patients, and we studied the molecula
r pathology of this disorder in an attempt to understand the molecular
basis of the clinical variation. We previously reported a T833C trans
ition in exon 8 causing a substitution of threonine for isoleucine at
codon 278 (I278T). By PCR amplification and sequencing of exon 8 from
genomic DNA we have now detected the I278T mutation in 7 of 11 patient
s with in vivo pyridoxine responsiveness and in 0 of 27 pyridoxine-non
responsive patients. Two pyridoxine-responsive patients are homezygous
and five are heterozygous for I278T. We have now observed the I278T m
utation in 41% (9 of 22) of the independent alleles in pyridoxine-resp
onsive patients of varied ethnic backgrounds. In two of the compound h
eterozygotes we identified a novel mutation (G139R and E144K) in the o
ther allele. The finding that the two patients who are homozygous for
I278T have only ectopia lentis and mild bone demineralization suggests
that this mutation is associated with both in vivo pyridoxine respons
iveness and mild clinical disease. Compound heterozygous patients who
have one copy of this missense mutation are likely to retain some degr
ee of pyridoxine responsiveness.